Kiadis Pharma NV (FRA:K3P) Change In Receivables : €-1.96 Mil (TTM As of Dec. 2020)

Kiadis Pharma NV Change In Receivables Chart

Kiadis Pharma NV Annual Data
	Trend	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20
Change In Receivables		Get a 7-Day Free Trial				-0.06	-0.78	-0.79	0.10	-1.96

Kiadis Pharma NV Semi-Annual Data
	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
Change In Receivables	Get a 7-Day Free Trial											-0.14	-0.94	1.03	0.80	-2.76

Kiadis Pharma NV Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2020 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kiadis Pharma NV  (FRA:K3P) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Kiadis Pharma NV's Days Sales Outstanding for the quarter that ended in Dec. 2020 is calculated as:

2. In Ben Graham's calculation of liquidation value, Kiadis Pharma NV's accounts receivable are only considered to be worth 75% of book value:

Kiadis Pharma NV's liquidation value for the quarter that ended in Dec. 2020 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kiadis Pharma NV Change In Receivables Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiadis Pharma NV (FRA:K3P) Business Description